Infection control measures to limit the spread of Clostridium difficile

被引:221
作者
Vonberg, R. -P. [1 ]
Kuijper, E. J. [2 ,8 ]
Wilcox, M. H. [3 ,4 ]
Barbut, F. [5 ]
Tull, P. [6 ]
Gastmeier, P. [1 ]
van den Broek, P. J. [2 ,8 ]
Colville, A. [7 ]
Coignard, B. [9 ]
Daha, T. [10 ]
Debast, S. [11 ]
Duerden, B. I. [12 ]
van den Hof, S. [13 ]
van der Kooi, T. [13 ]
Maarleveld, H. J. H. [8 ]
Nagy, E. [14 ]
Notermans, D. W. [13 ]
O'Driscoll, J. [15 ]
Patel, B. [16 ]
Stone, S. [17 ]
Wiuff, C. [18 ]
机构
[1] Hannover Med Sch, Inst Med Microbiol, D-30625 Hannover, Germany
[2] Hannover Med Sch, Hosp Epidemiol, D-30625 Hannover, Germany
[3] Leeds Teaching Hosp, Dept Microbiol, Leeds, W Yorkshire, England
[4] Univ Leeds, Leeds, W Yorkshire, England
[5] Hop St Antoine, Unite Hygiene & Lutte Contre Infect Nosocomiales, F-75571 Paris, France
[6] ECDC, Stockholm, Sweden
[7] Royal Devon & Exeter Hosp NHS Fdn Trust, Exeter, Devon, England
[8] Leiden Univ, Med Ctr, Leiden, Netherlands
[9] Inst Veille Sanitaire, St Maurice, France
[10] Dutch Working Party Infect Control, Leiden, Netherlands
[11] Meander Med Ctr, Amersfoort, Netherlands
[12] Dept Hlth, London SE1 6TE, England
[13] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, NL-3720 BA Bilthoven, Netherlands
[14] Univ Szeged, Fac Med, Inst Clin Microbiol, Szeged, Hungary
[15] Stoke Mandeville Hosp, Aylesbury, Bucks, England
[16] Hlth Protect Agcy, London, England
[17] UCL Royal Free & Univ Coll Med Sch, Acad Dept Geriatr Med, London WC1E 6BT, England
[18] Hlth Protect Scotland, Glasgow, Lanark, Scotland
关键词
Clostridium difficile; evidence-based guidelines; infection control measures;
D O I
10.1111/j.1469-0691.2008.01992.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Clostridium difficile-associated diarrhoea (CDAD) presents mainly as a nosocomial infection, usually after antimicrobial therapy. Many outbreaks have been attributed to C. difficile, some due to a new hypervirulent strain that may cause more severe disease and a worse patient outcome. As a result of CDAD, large numbers of C. difficile spores may be excreted by affected patients. Spores then survive for months in the environment; they cannot be destroyed by standard alcohol-based hand disinfection, and persist despite usual environmental cleaning agents. All these factors increase the risk of C. difficile transmission. Once CDAD is diagnosed in a patient, immediate implementation of appropriate infection control measures is mandatory in order to prevent further spread within the hospital. The quality and quantity of antibiotic prescribing should be reviewed to minimise the selective pressure for CDAD. This article provides a review of the literature that can be used for evidence-based guidelines to limit the spread of C. difficile. These include early diagnosis of CDAD, surveillance of CDAD cases, education of staff, appropriate use of isolation precautions, hand hygiene, protective clothing, environmental cleaning and cleaning of medical equipment, good antibiotic stewardship, and specific measures during outbreaks. Existing local protocols and practices for the control of C. difficile should be carefully reviewed and modified if necessary.
引用
收藏
页码:2 / 20
页数:19
相关论文
共 176 条
[1]   Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates [J].
Åkerlund, T ;
Svenungsson, B ;
Lagergren, Å ;
Burman, LG .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (02) :353-358
[2]  
al-Barrak A, 1999, Can Commun Dis Rep, V25, P65
[3]   A WIDESPREAD EPIDEMIC OF MILD NECROTIZING ENTEROCOLITIS OF UNKNOWN CAUSE [J].
ANDERSON, CL ;
COLLIN, MF ;
OKEEFE, JP ;
CHALLAPALLI, M ;
MYERS, TF ;
CALDWELL, CC ;
AHMED, GSS .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1984, 138 (10) :979-983
[4]  
[Anonymous], 2007, Clin Infect Dis
[5]   Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis [J].
Ansari, F ;
Gray, K ;
Nathwani, D ;
Phillips, G ;
Ogston, S ;
Ramsay, C ;
Davey, P .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (05) :842-848
[6]   ANTIMICROBIAL AGENTS AND CLOSTRIDIUM-DIFFICILE IN ACUTE ENTERIC DISEASE - EPIDEMIOLOGICAL DATA FROM SWEDEN, 1980-1982 [J].
ARONSSON, B ;
MOLLBY, R ;
NORD, CE .
JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (03) :476-481
[7]   Effects of piperacillin/tazobactam on Clostridium difficile growth and toxin production in a human gut model [J].
Baines, SD ;
Freeman, J ;
Wilcox, MH .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (06) :974-982
[8]   Tigecycline does not induce proliferation or cytotoxin production by epidemic Clostridium difficile strains in a human gut model [J].
Baines, Simon D. ;
Saxton, Katie ;
Freeman, Jane ;
Wilcox, Mark H. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (05) :1062-1065
[9]   Prevalence and pathogenicity of Clostridium difficile in hospitalized patients - A french multicenter study [J].
Barbut, F ;
Corthier, G ;
Charpak, Y ;
Cerf, M ;
Monteil, H ;
Fosse, T ;
Trevoux, A ;
DeBarbeyrac, B ;
Boussougant, Y ;
Tigaud, S ;
Tytgat, F ;
Sedallian, A ;
Duborgel, S ;
Collignon, A ;
LeGuern, ME ;
Bernasconi, P ;
Petit, JC .
ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (13) :1449-1454
[10]   USE OF THE ARBITRARY PRIMER POLYMERASE CHAIN-REACTION FOR INVESTIGATING AN OUTBREAK OF CLOSTRIDIUM-DIFFICILE-ASSOCIATED DIARRHEA IN AIDS PATIENTS [J].
BARBUT, F ;
MARIO, N ;
FROTTIER, J ;
PETIT, JC .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1993, 12 (10) :794-795